Mitral Valve Prolapse in Marfan Syndrome: An Old Topic Revisited

被引:35
作者
Taub, Cynthia C. [1 ]
Stoler, Joan M. [1 ]
Perez-Sanz, Teresa [1 ]
Chu, John [1 ]
Isselbacher, Eric M. [1 ]
Picard, Michael H. [1 ]
Weyman, Arthur E. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA USA
来源
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES | 2009年 / 26卷 / 04期
关键词
Marfan syndrome; mitral valve prolapse; echocardiography; NATURAL-HISTORY; FIBRILLIN-1; GENE; MUTATIONS; DIAGNOSIS; FBN1; PREVALENCE; PHENOTYPE; FEATURES; MANAGEMENT; CHILDHOOD;
D O I
10.1111/j.1540-8175.2008.00825.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The echocardiographic features of mitral valve prolapse (MVP) in Marfan syndrome have been well described, and the incidence of MVP in Marfan syndrome is reported to be 40-80%. However, most of the original research was performed in the late 1980s and early 1990s, when the diagnostic criteria for MVP were less specific. Our goal was to investigate the characteristics of MVP associated with Marfan syndrome using currently accepted diagnostic criteria for MVP. Methods: Between January 1990 and March 2004, 90 patients with definitive diagnosis of Marfan syndrome (based on standardized criteria with or without genetic testing) were referred to Massachusetts General Hospital for transthoracic echocardiography. Patients' gender, age, weight, height, and body surface area at initial examination were recorded. Mitral valve thickness and motion, the degree of mitral regurgitation and aortic regurgitation, and aortic dimensions were quantified blinded to patients' clinical information. Results: There were 25 patients (28%) with MVP, among whom 80% had symmetrical bileaflet MVP. Patients with MVP had thicker mitral leaflets (5.0 +/- 1.0 mm vs. 1.8 +/- 0.5 mm, P < 0.001), more mitral regurgitation (using a scale of 1-4, 2.2 +/- 1.0 vs. 0.90 +/- 0.60, P < 0.0001), larger LVEDD, and larger dimensions of sinus of Valsalva, sinotubular junction, aortic arch, and descending aorta indexed to square root body surface area, when compared with those without MVP. When echocardiographic features of patients younger than 18 years of age and those of patients older than 18 were compared, adult Marfan patients had larger LA dimension (indexed to square root body surface area), larger sinotubular junction (indexed to square root body surface area), and more mitral regurgitation and aortic regurgitation. Conclusions: The prevalence of MVP in Marfan syndrome is lower than previously reported. The large majority of patients with MVP have bileaflet involvement, and those with MVP have significantly larger aortic root diameters, suggesting a diffuse disease process. (ECHOCARDIOGRAPHY, Volume 26, April 2009).
引用
收藏
页码:357 / 364
页数:8
相关论文
共 39 条
[1]   A novel de novo mutation in exon 14 of the fibrillin-1 gene associated with delayed secretion of fibrillin in a patient with a mild Marfan phenotype [J].
Booms, P ;
Withers, AP ;
Boxer, M ;
Kaufmann, UC ;
Hagemeier, C ;
Vetter, U ;
Robinson, PN .
HUMAN GENETICS, 1997, 100 (02) :195-200
[2]   Novel exon skipping mutation in the fibrillin-1 gene: Two 'hot spots' for the neonatal Marfan syndrome [J].
Booms, P ;
Cisler, J ;
Mathews, KR ;
Godfrey, M ;
Tiecke, F ;
Kaufmann, UC ;
Vetter, U ;
Hagemeier, C ;
Robinson, PN .
CLINICAL GENETICS, 1999, 55 (02) :110-117
[3]   ECHOCARDIOGRAPHIC ASSESSMENT OF CARDIOVASCULAR-ABNORMALITIES IN THE MARFAN-SYNDROME - COMPARISON WITH CLINICAL FINDINGS AND WITH ROENTGENOGRAPHIC ESTIMATION OF AORTIC ROOT SIZE [J].
COME, PC ;
FORTUIN, NJ ;
WHITE, RI ;
MCKUSICK, VA .
AMERICAN JOURNAL OF MEDICINE, 1983, 74 (03) :465-474
[4]   A critical analysis of minor cardiovascular criteria in the diagnostic evaluation of patients with Marfan syndrome [J].
De Backer, Julie ;
Loeys, Bart ;
Devos, Dan ;
Dietz, Harry ;
De Sutter, Johan ;
De Paepe, Anne .
GENETICS IN MEDICINE, 2006, 8 (07) :401-408
[5]  
DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO
[6]  
2-R
[7]   DIAGNOSIS AND CLASSIFICATION OF SEVERITY OF MITRAL-VALVE PROLAPSE - METHODOLOGIC, BIOLOGIC, AND PROGNOSTIC CONSIDERATIONS [J].
DEVEREUX, RB ;
KRAMERFOX, R ;
SHEAR, MK ;
KLIGFIELD, P ;
PINI, R ;
SAVAGE, DD .
AMERICAN HEART JOURNAL, 1987, 113 (05) :1265-1280
[8]   MARFAN-SYNDROME CAUSED BY A RECURRENT DENOVO MISSENSE MUTATION IN THE FIBRILLIN GENE [J].
DIETZ, HC ;
CUTTING, GR ;
PYERITZ, RE ;
MASLEN, CL ;
SAKAI, LY ;
CORSON, GM ;
PUFFENBERGER, EG ;
HAMOSH, A ;
NANTHAKUMAR, EJ ;
CURRISTIN, SM ;
STETTEN, G ;
MEYERS, DA ;
FRANCOMANO, CA .
NATURE, 1991, 352 (6333) :337-339
[9]  
Figueiredo S, 2001, Rev Port Cardiol, V20, P1203
[10]   Prevalence and clinical outcome of mitral-valve prolapse [J].
Freed, LA ;
Levy, D ;
Levine, RA ;
Larson, MG ;
Evans, JC ;
Fuller, DL ;
Lehman, B ;
Benjamin, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (01) :1-7